WuXi dives in­to com­pu­ta­tion­al drug dis­cov­ery, launch­es New York-based JV with Schrödinger

Glob­al CRO pow­er­house WuXi AppTec has long made it clear that it’s not con­tent just do­ing out­sourced work for its clients. It’s in­vest­ed in R&D fa­cil­i­ties, seed­ed biotech star­tups and teamed up with Juno Ther­a­peu­tics to build a CAR-T com­pa­ny in Chi­na. And in its lat­est move in the US, WuXi is launch­ing a joint drug dis­cov­ery ven­ture with the com­pu­ta­tion­al chem­istry ex­perts at Schrödinger.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER